Gene · 871
NIH grants1,591
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,591
Download this page as JSON| Grant | Title | SERPINH1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA218513 | Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection | 1 | 2025 |
| R01CA243142 | Regulation of tumor recurrence by stress activated neutrophils | 1 | 2025 |
| R01CA252055 | Regulation of DGAT - dependent lipogenesis in colonic epithelial growth | 1 | 2025 |
| R01CA256833 | BBOX1 is a Novel Oncogenic Driver in Triple Negative Breast Cancer | 1 | 2025 |
| R01CA258314 | Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer | 1 | 2025 |
| R01CA260857 | Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy | 1 | 2025 |
| R01CA260872 | A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients | 1 | 2025 |
| R01CA261691 | anti-miR-10b Nanodrug for Treatment of Breast Cancer Metastasis: Study in Companion Animals | 1 | 2025 |
| R01DA058458 | Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders | 1 | 2025 |
| R01DK075787 | Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum | 1 | 2025 |
| R01DK091183 | Transcriptional co-regulators and macrophage gene expression | 1 | 2025 |
| R01DK113159 | A Molecular Approach to the Pathogenesis of Portal Hypertension | 1 | 2025 |
| R01DK116548 | Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria | 1 | 2025 |
| R01DK117861 | Molecular Mechanisms of Cholestatic Fibrogenesis | 1 | 2025 |
| R01DK119767 | Jagged-Notch signaling in NASH/fibrosis | 1 | 2025 |
| R01DK125465 | The Immune Response After Drug Induced Hepatotoxicity | 1 | 2025 |
| R01DK131101 | Molecular Pathobiology of Alport Syndrome | 1 | 2025 |
| R01DK136016 | Hepatic stellate cell plasticity and maladaptive fibrogenic memory in chronic liver disease | 1 | 2025 |
| R01EY005121 | RPE Messengers, Transcription and Photoreceptor Renewal | 1 | 2025 |
| R01EY005665 | Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/grants?page=8